Skip to content
drillr.ai
Sign up

4594.T

BrightPath Biotherapeutics Co.,Ltd.

グロース · 医薬品 · 医薬品 · JP

JPY 52.00
+0.00%
Ask drillr

  • Aug 14, 2026, 06:32 UTC

    BrightPath Biophotonics announced its fiscal Q1 (April-June) results on August 14, reporting an expanded recurring loss of 540 million yen, compared with a 240 million yen loss in the same period last year.

    Source: